Physicochemical Properties
| Molecular Formula | C18H18CLNOS |
| Molecular Weight | 331.858 |
| Exact Mass | 331.079 |
| Elemental Analysis | C, 65.15; H, 5.47; Cl, 10.68; N, 4.22; O, 4.82; S, 9.66 |
| CAS # | 1802013-08-6 |
| PubChem CID | 124201848 |
| Appearance | White to off-white solid powder |
| Density | 1.2±0.1 g/cm3 |
| Boiling Point | 484.5±45.0 °C at 760 mmHg |
| Flash Point | 246.8±28.7 °C |
| Vapour Pressure | 0.0±1.2 mmHg at 25°C |
| Index of Refraction | 1.604 |
| LogP | 5.76 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 2 |
| Heavy Atom Count | 22 |
| Complexity | 403 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | RDMUJSJZBYAAEF-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C18H18ClNOS/c1-11(2)13-5-3-4-6-14(13)18-15-9-12(19)7-8-16(15)20-17(21)10-22-18/h3-9,11,18H,10H2,1-2H3,(H,20,21) |
| Chemical Name | 7-chloro-5-(2-propan-2-ylphenyl)-1,5-dihydro-4,1-benzothiazepin-2-one |
| Synonyms | ITH12575; ITH 12575; ITH-12575 |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References |
[1]. Benzothiazepine CGP37157 Analogues Exert Cytoprotection in Various in Vitro Models of Neurodegeneration. ACS Chem Neurosci. 2015 Sep 16;6(9):1626-36. [2]. Benzothiazepine CGP37157 and its 2'-isopropyl analogue modulate Ca2+ entry through CALHM1. Neuropharmacology. 2015 Aug;95:503-10. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~50 mg/mL (~150.67 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (7.53 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.0133 mL | 15.0666 mL | 30.1332 mL | |
| 5 mM | 0.6027 mL | 3.0133 mL | 6.0266 mL | |
| 10 mM | 0.3013 mL | 1.5067 mL | 3.0133 mL |